SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-034745
Filing Date
2021-10-18
Accepted
2021-10-18 16:30:47
Documents
13
Period of Report
2021-10-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K brhc10029900_8k.htm   iXBRL 8-K 23444
5 image0.jpg GRAPHIC 32875
  Complete submission text file 0001140361-21-034745.txt   240926

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA cemi-20211016.xsd EX-101.SCH 3920
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE cemi-20211016_lab.xml EX-101.LAB 22544
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cemi-20211016_pre.xml EX-101.PRE 16040
6 EXTRACTED XBRL INSTANCE DOCUMENT brhc10029900_8k_htm.xml XML 4053
Mailing Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788
Business Address 555 WIRELESS BLVD. HAUPPAUGE NY 11788 (631) 924-1135
CHEMBIO DIAGNOSTICS, INC. (Filer) CIK: 0001092662 (see all company filings)

IRS No.: 880425691 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35569 | Film No.: 211328542
SIC: 2834 Pharmaceutical Preparations